Unknown

Dataset Information

0

Evaluation of Financial Conflicts of Interest and Drug Statements in the Coronavirus Disease 2019 Clinical Practice Guideline in Japan.

ABSTRACT:

SUBMITTER: Hashimoto T 

PROVIDER: S-EPMC8610564 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Financial Conflicts of Interest in Clinical Practice Guidelines: A Systematic Review.
| S-EPMC8105509 | biostudies-literature
Unknown Coronavirus disease 2019 experts appearing on Japanese television: their characteristics and financial conflicts of interest with pharmaceutical companies.
| S-EPMC8494614 | biostudies-literature
Unknown Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines.
| S-EPMC5571907 | biostudies-literature
Unknown Drivers of the opioid crisis: An appraisal of financial conflicts of interest in clinical practice guideline panels at the peak of opioid prescribing.
| S-EPMC6980493 | biostudies-literature
Unknown Investigator experiences with financial conflicts of interest in clinical trials.
| S-EPMC3031202 | biostudies-literature
Unknown Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study.
| S-EPMC6661552 | biostudies-literature
Unknown Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study.
| S-EPMC3191201 | biostudies-literature
Unknown Financial Conflicts of Interest and Stance on Tobacco Harm Reduction: A Systematic Review.
| S-EPMC6603486 | biostudies-literature
Unknown Disclosure of financial conflicts of interest: an evaluation of orthopaedic surgery patients' understanding.
| S-EPMC3549175 | biostudies-literature
Unknown Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.
| S-EPMC6487566 | biostudies-literature